The administration of IVFs is nearly universal in critically ill patients. In recent years, several studies have suggested improved outcomes with the use of balanced crystalloids solutions in contrast to 0.9% NS. In this podcast, we discuss the recently published BaSICS Trial that evaluated Plasma-Lyte 148 with 0.9% NS in critically ill patients. Does this study provide practice-changing evidence to make that switch?
You can get CME credit for this episode hereClick here for CME Account Creation Instructions
In December 2019 a novel coronavirus (now named COVID-19) was identified as responsible for a cluster of pneumonia cases in Wuhan, China. As of...
These are some of the sickest patients you’ll see in the ED and ICU. In this episode, we discuss incredibly useful pearls and pitfalls...
The period following ROSC from cardiac arrest is a time when lives can be saved…or lost. A systematic and comprehensive approach to post-arrest care...